Centers for Disease Control and Prevention. Measles, mumps, rubella-vaccine use and strategies for elimination of measles, rubella, and con- genital rubella syndrome and control of mumps. Recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report
1998; 47(RR-8): 1–58.
American Academy of Pediatrics. Measles. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases, 24th edn.
Elk Grove Village, IL: American Academy of Pediatrics, 1997, pp. 344–357.
Centers for Disease Control and Prevention. Summary of notifiable diseases, United States 1998. Morbidity and Mortality Weekly Report
1999; 47; 78–84.
Centers for Disease Control and Prevention. Epidemiology of measles – United States, 1998. Morbidity and Mortality Weekly Report
1999; 48; 749–753.
Pan American Health Organization, Division of Vaccines and Immunization, 2000 Expanded Program on Immunization. 2000 Measles surveillance in the Americas. Weekly Bulletin, 24 June 2000, 6(25).
Blumberg S, et al.
Identifying post elimination trends for the introduction and transmissibility of measles in the united states. American Journal of Epidemiology
2014; 179: 1375–1382.
McCarthy M. Measles outbreak linked to Disney theme parks reaches five states and Mexico. British Medical Journal
2015; 350: h436.
McCarthy M. Measles cases exceed 100 in US outbreak, British Medical Journal
2015; 350: h622.
Parker AA, et al.
Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. New England Journal of Medicine
2006; 355, 447–455.
Camargo MCC, et al.
Predictors related to the occurrence of a measles epidemic in the city of Sao Paulo in 1997. Revista Panamericana de Salud Publica
2006; 7: 359–365.
Domingues CMAS, et al.
National immunization program: vaccination, compliance and pharmacovigilance. Revista do Instituto de Medicina Tropical de Sao Paulo
2012; 54: 22–27.
Sniadack DH, et al.
Epidemiology of a measles epidemic in Vietnam 2008–2010. Journal of Infectious Diseases
2011; 204: S476–S482.
Antona D, et al.
Measles elimination efforts and 2008–2011 outbreak, France. Emerging Infectious Diseases
2013; 19: 357.
Hennessey KA, et al.
Measles epidemic in Romania, 1996–1998; assessment of vaccine effectiveness by case-control and cohort studies. American Journal of Epidemiology
1999; 150: 1250–1257.
Grais RF, et al.
Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad. PLoS Medicine
2004; 4: e16.
Shibeshi ME, et al.
Measles resurgence in southern Africa: challenges to measles elimination. Vaccine
2014; 32: 1798–1807.
Minetti A, et al.
Lessons and challenges for measles control from unexpected large outbreak, Malawi. Emerging Infectious Diseases
2013; 19: 202.
Chen RT, et al.
A ‘post-honeymoon period’ measles outbreak in Muyinga sector, Burundi. International Journal of Epidemiology
1994; 23: 185–193.
Cummings DA, et al.
Improved measles surveillance in Cameroon reveals two major dynamic patterns of incidence. International Journal of Infectious Diseases
2006; 10: 148–155.
Masuet-Aumatell C, et al.
Measles in Bolivia: a ‘honeymoon period’. Vaccine
2013; 31: 2097–2102.
McLean AR. Vaccines and their impact on the control of disease. British Medical Bulletin
1998; 54: 545–556.
McLean AR, Anderson RM. Measles in developing countries. Part I. Epidemiological parameters and patterns, Epidemiology and Infection
1988; 100: 111–133.
Scherer A, McLean A. Mathematical models of vaccination. British Medical Bulletin
2000; 62: 187–199.
McLean AR, Anderson RM. Measles in developing countries. Part II. The predicted impact of mass vaccination, Epidemiology and Infection
1998; 100: 419–442.
Orenstein WA, Measles eradication: is it in our future?
American Journal of Public Health
2000; 90: 1521–1525.
Katz SL, et al.
Global measles elimination efforts: the significance of measles elimination in the United States. Journal of Infectious Diseases
2004; 189: S251–S257.
Orenstein WA, Gay NJ. The theory of measles elimination: implications for the design of elimination strategies. Journal of Infectious Diseases
2004; 189: S27–S35.
Anderson RM, May RM. Infectious Diseases of Humans. Oxford: Oxford University Press, 1991.
Castillo-Chavez C, et al.
Epidemiological models with age structure, proportionate mixing, and cross-immunity. Journal of Mathematical Biology
1989; 27: 233–258.
McLean AR. After the honeymoon in measles control. Lancet
1995; 345: 272–280.
Mossong J, et al.
Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine
2008, 5: e74.
Fumanelli L, et al.
Inferring the structure of social contacts from demographic data in the analysis of infectious diseases spread. PLoS Computational Biology
2012; 8: e1002673.
Gillespie DT, Approximate accelerated stochastic simulation of chemically reacting systems. Journal of Chemical Physics
2001; 115: 1716–1733.
McKee A, Ferrari MJ, Shea K. The effects of maternal immunity and age structure on population immunity to measles. Theoretical Ecology
2015; 8: 261–271.
Mossong J, Muller CP. Modelling measles re-emergence as a result of waning of immunity in vaccinated populations. Vaccine
2003; 21: 4597–4603.
Earn DJ, et al.
A simple model for complex dynamical transitions in epidemics. Science
2005; 287: 667–670.
Heffernan JM, Smith RJ, Wahl LM. Perspectives on the basic reproductive ratio. Journal of the Royal Society Interface
2005; 2: 281–293.
Simons E, et al.
Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet
2012; 379: 2173–2178.
Bishai D. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda. Journal of Infectious Diseases
2011; 204: S107–S115.
Uzicanin A, et al.
Impact of the 1996–1997 supplementary measles vaccination campaigns in South Africa. International Journal of Epidemiology
2002; 31: 968–976.
Andrus JK, et al.
Measles and rubella eradication in the Americas. Vaccine
2011; 29: D91–D96.
World Health Organization.
Global measles mortality reduction and regional elimination strategic plan 2001–2005
. Geneva, Switzerland: World Health Organization; 2001.